Seeing well-controlled Phase 3 data that shows a marked slowing of lesion growth in Stargardt disease is deeply encouraging
The Complement Laboratory is equipped with state-of-the-art immunoturbidimetric and ELISA platforms and adheres to CAP and NABL accreditation standards
Surgical site infections and antimicrobial resistance remain major challenges globally
_256_384.png)
India presents one of the world’s largest untapped opportunities for neurovascular screening
The modular platform not only targets solid tumors but could also enhance traditional autologous and in vivo T cell therapies
Sepsis is a life-threatening reaction to infection that overwhelms the body’s defenses
This approval is based on positive results from two Phase 3, global, double-blind, placebo-controlled trials
The integration of AHG’s specialized cold chain transportation and third-party logistics (3PL) solutions will significantly strengthen UPS Healthcare’s service offerings
Subscribe To Our Newsletter & Stay Updated
